InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,166.40
(
0.51%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,210.14
(
0.31%
)
Post# of 252184
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

10nisman

Send PM Follow Ignore
Followers 24
Posts 2529
Boards Moderated 0
Alias Born 10/26/2003

10nisman

Re: randychub post# 22568

Tuesday, 01/24/2006 12:25:10 PM

Tuesday, January 24, 2006 12:25:10 PM

Post# of 252184
imcl - Why put yourself up for sale at this point when the completion of these trials is so close? Why not wait?

My opinion is Risk/Return. If IMCL can cash in at say a 38% premium over the current market price or about $47 regardless of risk of the trial data why not sell? Its similar to GTCB selling shares ahead of approval. I think IMCL will try and get a nice takeout package, lock in some nice capital gains for its employees and executives, and it gives them the opportunity to advance its current and future trials with nearly endless capital. Big pharma needs a pipeline so why not sell out?

Dew, what are your thoughts?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up